REG - EMV Capital PLC - Director/PDMR Shareholding

EMV CapitalAnnouncement

03/10/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241003:nRSC7348Ga&default-theme=true

RNS Number : 7348G  EMV Capital PLC  03 October 2024

EMV Capital plc

 

("EMV Capital" or the "Company")

 

Director/PDMR Shareholding

 

EMV Capital plc (AIM: EMVC), the deeptech and life sciences VC investment
group, announces that on 2 October 2024, Dr Jonathan Robinson (Senior
Independent Director) purchased 25,000 ordinary shares in the capital of EMV
Capital plc ("Ordinary Shares") through his Self-Invested Personal Pension.

 

Following such purchase, Dr Robinson is interested in 199,253 Ordinary Shares,
representing 0.82 per cent. of the entire issued share capital of the Company.

 

The information below, set out in accordance with the requirements of
the UK Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Dr Jonathan Robinson
 2    Reason for the notification
 a)   Position/status                                              Director
 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         EMV Capital plc
 b)   LEI                                                          213800N5WD46G1Y7I458
 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  EMVC 5p Ordinary Shares

      Identification code

                                                                   GB00BN4R5Q82
 b)   Nature of the transaction                                    Purchase of Ordinary Shares into SIPP
 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   £0.52     25,000 shares

 
 d)   Aggregated information

       - Aggregated volume

Price   Volume

       - Price                                                     £0.52   25,000 shares

 e)   Date of the transaction                                      2 October 2024

 f)   Place of the transaction                                     UK AIM

 

d)

 

Aggregated information

 - Aggregated volume

 

 - Price

 

 

 

 Price   Volume

 £0.52   25,000 shares

e)

 

Date of the transaction

2 October 2024

f)

 

Place of the transaction

UK AIM

 

#  #  #

 

 For more information, please contact:
 EMV Capital plc                                                             via Rosewood
 Ilian Iliev, CEO

 Panmure Liberum (UK) Limited (NOMAD and Broker)                             +44 (0)20 7886 2500
 Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance)
 Rupert Dearden (Corporate Broking)

 Rosewood (Financial PR)                                                     +44 (0)20 7653 8702
 John West / Llewellyn Angus / Lily Pearce

 

About EMV Capital plc (EMVC)

EMV Capital plc, formerly known as NetScientific plc, is a deep tech and life
sciences venture capital investment group with an international portfolio of
high-growth companies.

 

With a strategic focus on generating superior returns for investors from the
fast-growing sectors and technologies that will define our future; EMV Capital
invests in, manages and strengthens early stage IP-rich companies.

 

EMV Capital holds both direct equity stakes and carried interest in its
portfolio companies, creating an evergreen structure that supports extensive
growth and value creation. EMV Capital's investment thesis is realised through
these capital sources:

 

·     capital-efficient investments through Group balance sheet;

·     fund management of the Evergreen EIS and Martlet Capital Funds;

·     syndicated investments leveraging its network of third-party
investors.

 

EMV Capital's approach is characterised by its proactive management style,
aiming to advance portfolio companies to critical value inflection points by
actively engaging with them. Companies are supported through Board
representation and the use of its Value Creation Services practice.

 

Headquartered in London, with a Cambridge presence and strong international
links, EMV Capital is quoted on the AIM market of the London Stock Exchange.

 

www.emvcapital.com (http://www.emvcapital.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUUURRSUURRUA